Announced Thu, 28 May · 16:18 IST

Newspaper Publication of Audited Financial Results for Quarter and Year ended March 31, 2026

JHS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.6%1-day move
₹9.36
prior close
₹9.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.5-0.4-2.2-5.6-6.5-5.3-10.4-5.8-14.3-14.5-20.4
Up moveDown movePending
AI summary

JHS Svendgaard Laboratories has published its audited financial results for Q4 and full year FY26 in Business Standard newspapers. The company reported total income of Rs. 7,308.92 lakh for Q4 FY26 and Rs. 9,200.82 lakh for the full year. However, the company continues to incur significant losses with net loss after tax of Rs. 6,589.47 lakh in Q4 and Rs. 18,953.52 lakh for FY26. Total comprehensive loss stood at Rs. 18,971.31 lakh for the year. Equity share capital remains at Rs. 876.68 lakh, while reserves have deteriorated to negative Rs. 26,759.30 lakh. Earnings per share is deeply negative at Rs. 15.02 for Q4 and Rs. 43.47 for the year on basic EPS. The Board approved the results on May 27, 2026, with the company operating under accumulated losses.

Likely market impact

The company remains deeply loss-making with accumulated reserves in negative territory, indicating significant erosion of shareholder value. Investors should be cautious as operational sustainability concerns persist.